WHO Drug Information Vol. 20, No. 1, 2006 - World Health ...

More documents

Recommendations

Info

WHO Drug Information, Vol. 20, No. 1, 2006 Recommended INN: List 55mapatumumabummapatumumabmapatumumabmapatumumabimmunoglobulin G1, anti-(human cytokine receptor DR4 (deathreceptor 4))(human monoclonal TRM-1 heavy chain), disulfide withhuman monoclonal TRM-1 λ-chain, dimerimmunoglobuline G1, anti-(élément 10A humain dans la« superfamille » du récepteur du facteur de nécrose tumorale(récepteur DR4)), dimère du disulfure entre la chaîne lourde et lachaîne λ de l’anticorps monoclonal humain TRM-1inmunoglobulina G1, anti-(elemento 10A humano de la« superfamilia » del receptor del factor de necrosis tumoral (receptorDR4)), dímero del disulfuro entre la cadena pesada y la cadena λdel anticuerpo monoclonal humano TRM-1C 6748H 10408N 1800O 2092S 52nebicaponumnebicaponenébicaponenebicapone1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethan-1-one1-(3,4-dihydroxy-5-nitrophényl)-2-phényléthanone1-(3,4-dihidroxi-5-nitrofenil)-2-feniletan-1-onaC 14H 11NO 5O 2 NOHOOHnerispirdinumnerispirdinenérispirdinenerispirdinaN-(3-fluoropyridin-4-yl)-3-methyl-N-propyl-1H-indol-1-amineN-(3-fluoropyridin-4-yl)-3-méthyl-N-propyl-1H-indol-1-amineN-(3-fluoroparidin-4-il)-3-metil-N-propil-1H-indol-1-aminaC 17H 18FN 3NFNNCH 3CH 345
Recommended INN: List 55 WHO Drug Information, Vol. 20, No. 1, 2006ofatumumabumofatumumabofatumumabofatumumabimmunoglobulin G1, anti-(human CD20 (antigen))(humanmonoclonal HuMax-CD20 heavy chain), disulfide with humanmonoclonal HuMax-CD20 κ-chain, dimerimmunoglobuline G1, anti-(antigène CD20 humain), dimère dudisulfure entre la chaîne lourde et la chaîne κ de l’anticorpsmonoclonal humain HuMax-CD20inmunoglobulina G1, anti-(antígeno CD20 humano), dímero deldisulfuro entre la cadena pesada y la cadena κ del anticuerpomonoclonal humano HuMax-CD20C 6480H 10022N 1742O 2020S 44olmesartanumolmesartanolmésartanolmesartán4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acidacide 4-(1-hydroxy-1-méthyléthyl)-2-propyl-1-[[2'-(1H-tétrazol-5-yl)=biphényl-4-yl]méthyl]-1H-imidazole-5-carboxyliqueácido 4-(2-hidroxipropan-2-il)-2-propil-1-{[2'-(1H-tetrazol-5-il)bifenil-4-il]metil}-1H-imidazol-5-carboxílicoC 24H 26N 6O 3H 3 CH 3 COH CO 2 HNNNHNNNCH 3padoporfinumpadoporfinpadoporfinepadoporfina{hydrogen 3-[(2 2 R,7R,8R,17S,18S)-12-acetyl-7-ethyl-2 2 -(methoxycarbonyl)-3,8,13,17-tetramethyl-2 1 -oxo-2 1 ,2 2 ,7,8,17,18-hexahydrocyclopenta[at]porphorin-18-yl]propanoatoκ4N21 ,N 22 ,N 23 ,N 24 }palladium(SP-4-2)-[hydrogéno-3-[(2 2 R,7R,8R,17S,18S)-12-acétyl-7-éthyl-2 2 -(méthoxycarbonyl)-3,8,13,17-tétraméthyl-2 1 -oxo-2 1 ,2 2 ,7,8,17,18-hexahydrocyclopenta[at]porphyrin-18-yl]propanoatoκN21 ,κN 22 ,κN 23 ,κN 24 ]palladium(SP-4-2)-[hidrógeno-3-[(2 2 R,7R,8R,17S,18S)-12-acetil-7-etil-2 2 -(metoxicarbonil)-3,8,13,17-tetrametil-2 1 -oxo-2 1 ,2 2 ,7,8,17,18-hexahidrociclopenta[at]porfirin-18-il]propanoatoκN21 ,κN 22 ,κN 23 ,κN 24 ]paladio46
Page 1 and 2: WHODRUGINFORMATIONV O L U M E 20•
Page 3 and 4: World Health OrganizationWHO Drug I
Page 5 and 6: Counterfeit MedicinesWHO Drug Infor
Page 7 and 8: Biological MedicinesWHO Drug Inform
Page 9 and 10: Biological MedicinesWHO Drug Inform
Page 11 and 12: Safety and Efficacy IssuesWHO Drug
Page 21 and 22: Access to MedicinesWHO Drug Informa
Page 27 and 28: WHO Drug Information Vol 20, No. 1,
Page 29 and 30: Regulatory Action and NewsWHO Drug
Page 31 and 32: Recent Publications, Information an
Page 33 and 34: Recent Publications, Information an
Page 35 and 36: General InformationWHO Drug Informa
Page 37 and 38: General InformationWHO Drug Informa
Page 39 and 40: Recommended INN: List 55 WHO Drug I
Page 45: Recommended INN: List 55 WHO Drug I
Page 59: Recommended INN: List 55 WHO Drug I

WHO Drug Information Vol. 20, No. 1, 2006 - World Health ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?